PlainRecalls
FDA Drug Moderate Class II Terminated

Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-448-90

Reported: August 3, 2022 Initiated: July 18, 2022 #D-1293-2022

Product Description

Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-448-90

Reason for Recall

Failed dissolution specifications.

Details

Units Affected
9,600 bottles
Distribution
Nationwide within the United States
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-448-90. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 9,600 bottles.
Why was this product recalled?
Failed dissolution specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 3, 2022. Severity: Moderate. Recall number: D-1293-2022.